The global enzymes market size accounted for USD 10.98 billion in 2024, grew to USD 11.42 billion in 2025 and is predicted to surpass around USD 16.26 billion by 2034, representing a healthy CAGR of 4% between 2024 and 2034. The North America enzymes market size is calculated at USD 4.17 billion in 2024 and is expected to grow at a fastest CAGR of 4.13% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Enzymes Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Enzymes Market, by Product, 2024-2034
8.1.1. Industrial Enzymes
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Specialty Enzymes
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Enzymes Market, by Type, 2024-2034
9.1.1. Carbohydrases
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Amylases
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Cellulases
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Proteases
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Lipases
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Polymerases & Nucleases
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2021-2034)
10.1. Enzymes Market, by Application, 2024-2034
10.1.1. Food and Beverages
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Meat processing products
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Dairy products
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Beverages
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Bakery & confectionary
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.2. Market Revenue and Forecast, by Type (2021-2034)
11.1.3. Market Revenue and Forecast, by Application (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Type (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Type (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.2. Market Revenue and Forecast, by Type (2021-2034)
11.2.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Type (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Type (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Type (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Type (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Application (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.2. Market Revenue and Forecast, by Type (2021-2034)
11.3.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Type (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Type (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Type (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Type (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Application (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.2. Market Revenue and Forecast, by Type (2021-2034)
11.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Type (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Type (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Type (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Type (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Application (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.2. Market Revenue and Forecast, by Type (2021-2034)
11.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Type (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Type (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Application (2021-2034)
12.1. BASF (Germany)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. DuPont (US)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Associated British Foods (UK)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Advanced Enzymes Technologies (India)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Aumgene Biosciences (India)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Chr Hansen (Denmark)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Creative Enzymes (US)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Enzyme Solutions (US)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Amano Enzymes (Japan)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Roche Holding (Switzerland)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample